SQSTM1 and COVID-19: According to the analysis of the SQSTM1/P62 gene, which is the hub gene associated with severe COVID-19, further survival analysis was performed for adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), glioblastoma (GBM), HPV-negative head and neck squamous cell carcinoma (HNSC), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), liver hepatocellular carcinoma (LIHC), sarcoma (SARC), thymoma (THYM), and uveal melanoma (UVM) (Figure 5e).